Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Study Shows How Deep Learning and AI Diagnose TB

By MedImaging International staff writers
Posted on 24 Apr 2017
Researchers have found that they can use an artificial intelligence technique called deep learning to identify cases of tuberculosis on chest X-Ray exams with a net accuracy rate of 96%.

According to the World Health Organization (WHO) around 1.8 million people died from tuberculosis (TB) in 2016. A simple chest X-Ray exam can help radiologists identify the disease, but many TB patients live in remote areas without access to expert radiologists who can interpret the images, and diagnose the disease.

The study was carried out by researchers at the Thomas Jefferson University Hospital who trained artificial intelligence models to identify TB on chest X-rays. The goal of the research was to help screen and evaluate patients in TB-prevalent areas lacking access to radiologists. The study was published in the April 25, 2017, online issue of the journal Radiology.

The researchers used 1,007 X-Ray exams of patients with and without active TB for the study. The multiple TB-positive and TB-negative X-Ray datasets were used to train two different Deep Convolutional Neural Network (DCNN) models called AlexNet and GoogLeNet. The researchers found that the best performing Artificial Intelligence (AI) model was when both AlexNet and GoogLeNet were used together, resulting in a net accuracy of 96%.

Co-author of the study, Paras Lakhani, MD at TJUH, said, “There is a tremendous interest in artificial intelligence, both inside and outside the field of medicine. An artificial intelligence solution that could interpret radiographs for presence of TB in a cost-effective way could expand the reach of early identification and treatment in developing nations. The relatively high accuracy of the deep learning models is exciting. The applicability for TB is important because it’s a condition for which we have treatment options. It’s a problem that can be solved. We hope to prospectively apply this in a real world environment. An artificial intelligence solution using chest imaging can play a big role in tackling TB.”


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
Brachytherapy Planning System
Oncentra Brachy
New
Compact C-Arm
Arcovis DRF-C S21
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.